Ammonia → HCID 101281155, compound
Reaction equation
C(Cl)(Cl)Cl.C(O)C.[NH3:8].[CH3:9][C@H:10]([NH2:35])[CH:11]1[O:16][C@@H:15]([O:17][C@H:18]2[C@H:23]([OH:24])[C@H:22]([N:25](C(CN)=O)[CH3:26])[C@@H:21]([O:31][CH3:32])[C@@H:20]([OH:33])[C@@H:19]2[NH2:34])[CH2:14][CH2:13][CH2:12]1>CC(C)=O>[CH3:9][C@H:10]([NH2:35])[C:11]1[O:16][C@H:15]([O:17][C@H:18]2[C@H:23]([OH:24])[C@H:22]([NH:25][CH3:26])[C@@H:21]([O:31][CH3:32])[C@@H:20]([OH:33])[C@@H:19]2[NH2:34])[C@H:14]([NH2:8])[CH2:13][CH:12]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
The crude powders are then subjected to silica gel column chromatography using a mixed solvent of chloroform, ethanol, aqueous ammonia and acetone (2:2:1:2, by volume) as a developer. The crude powder containing Fortimicin factors B, KE and KG is suspended in the solvent and introduced into the column. Development is carried out with the same solvent at a flow rate of about 30 ml/hour. First, Fortimicin B and Fortimicin KE are eluted and then Fortimicin KG is eluted. The active fractions containing Fortimicin KG are collected and concentrated under reduced pressure. The concentrate is freeze-dried to obtain the free base of Fortimicin KG.
Workup
- additionintroduced into the column
- washFirst, Fortimicin B and Fortimicin KE are eluted
- washFortimicin KG is eluted
- additionThe active fractions containing Fortimicin KG
- customare collected
- concentrationconcentrated under reduced pressure
- customThe concentrate is freeze-dried
Sources & evidence
- ORD record
- ord-8247fea6c93a45039404812714616fde
- Source dataset
- uspto-grants-1980_06
- Patent number
- US04209612
Reaction notes
Loading…